Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87.4M
Number of holders
43
Total 13F shares, excl. options
17.2M
Shares change
-1.26M
Total reported value, excl. options
$27.2M
Value change
-$2.9M
Number of buys
18
Number of sells
-16
Price
$1.58

Significant Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) as of Q1 2024

50 filings reported holding TOI - Oncology Institute, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.2M shares of 87.4M outstanding shares and own 19.69% of the company stock.
Largest 10 shareholders include FMR LLC (4.75M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.36M shares), VANGUARD GROUP INC (1.78M shares), Balyasny Asset Management L.P. (1.73M shares), Kent Lake Capital LLC (1.19M shares), Triatomic Management LP (885K shares), CINCINNATI INSURANCE CO (700K shares), TIFF ADVISORY SERVICES, LLC (423K shares), GEODE CAPITAL MANAGEMENT, LLC (354K shares), and FourWorld Capital Management LLC (250K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.